Literature DB >> 20356841

Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex.

Stepan Gambaryan1, Anna Kobsar, Natalia Rukoyatkina, Sabine Herterich, Joerg Geiger, Albert Smolenski, Suzanne M Lohmann, Ulrich Walter.   

Abstract

Protein kinase A (PKA) activation by cAMP phosphorylates multiple target proteins in numerous platelet inhibitory pathways that have a very important role in maintaining circulating platelets in a resting state. Here we show that in thrombin- and collagen-stimulated platelets, PKA is activated by cAMP-independent mechanisms involving dissociation of the catalytic subunit of PKA (PKAc) from an NFkappaB-IkappaBalpha-PKAc complex. We demonstrate mRNA and protein expression for most of the NFkappaB family members in platelets. From resting platelets, PKAc was co-immunoprecipitated with IkappaBalpha, and conversely, IkappaBalpha was also co-immunoprecipitated with PKAc. This interaction was significantly reduced in thrombin- and collagen-stimulated platelets. Stimulation of platelets with thrombin- or collagen-activated IKK, at least partly by PI3 kinase-dependent pathways, leading to phosphorylation of IkappaBalpha, disruption of an IkappaBalpha-PKAc complex, and release of free, active PKAc, which phosphorylated VASP and other PKA substrates. IKK inhibitor inhibited thrombin-stimulated IkBalpha phosphorylation, PKA-IkBalpha dissociation, and VASP phosphorylation, and potentiated integrin alphaIIbbeta3 activation and the early phase of platelet aggregation. We conclude that thrombin and collagen not only cause platelet activation but also appear to fine-tune this response by initiating downstream NFkappaB-dependent PKAc activation, as a novel feedback inhibitory signaling mechanism for preventing undesired platelet activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20356841      PMCID: PMC2881761          DOI: 10.1074/jbc.M109.077602

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Cyclic nucleotides and phosphodiesterases in platelets.

Authors:  R J Haslam; N T Dickinson; E K Jang
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway.

Authors:  M Leitges; L Sanz; P Martin; A Duran; U Braun; J F García; F Camacho; M T Diaz-Meco; P D Rennert; J Moscat
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

3.  Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.

Authors:  K W Kim; S H Kim; E Y Lee; N D Kim; H S Kang; H D Kim; B S Chung; C D Kang
Journal:  J Biol Chem       Date:  2001-01-29       Impact factor: 5.157

4.  Cyclic nucleotide-dependent protein kinases inhibit binding of 14-3-3 to the GTPase-activating protein Rap1GAP2 in platelets.

Authors:  Meike Hoffmeister; Pavel Riha; Olga Neumüller; Oliver Danielewski; Jan Schultess; Albert P Smolenski
Journal:  J Biol Chem       Date:  2007-11-26       Impact factor: 5.157

Review 5.  Shared principles in NF-kappaB signaling.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

Review 6.  Platelet activation and atherothrombosis.

Authors:  Giovanni Davì; Carlo Patrono
Journal:  N Engl J Med       Date:  2007-12-13       Impact factor: 91.245

7.  Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis.

Authors:  M Majka; A Janowska-Wieczorek; J Ratajczak; M A Kowalska; G Vilaire; Z K Pan; M Honczarenko; L A Marquez; M Poncz; M Z Ratajczak
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

Review 8.  Cell adhesion mechanisms in platelets.

Authors:  David Varga-Szabo; Irina Pleines; Bernhard Nieswandt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-03       Impact factor: 8.311

9.  NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity.

Authors:  S Gambaryan; A Kobsar; S Hartmann; I Birschmann; P J Kuhlencordt; W Müller-Esterl; S M Lohmann; U Walter
Journal:  J Thromb Haemost       Date:  2008-05-14       Impact factor: 5.824

10.  Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation.

Authors:  L A Moraes; M Spyridon; W J Kaiser; C I Jones; T Sage; R E L Atherton; J M Gibbins
Journal:  J Thromb Haemost       Date:  2009-12-21       Impact factor: 5.824

View more
  58 in total

Review 1.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

2.  Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclase.

Authors:  Barbara Lies; Dieter Groneberg; Stepan Gambaryan; Andreas Friebe
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

3.  Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity.

Authors:  Srikanth Nagalla; Chad Shaw; Xianguo Kong; Altaf A Kondkar; Leonard C Edelstein; Lin Ma; Junmei Chen; G Stanley McKnight; José A López; Linghai Yang; Ying Jin; Molly S Bray; Suzanne M Leal; Jing-Fei Dong; Paul F Bray
Journal:  Blood       Date:  2011-03-17       Impact factor: 22.113

4.  IκB kinase 2 is not essential for platelet activation.

Authors:  Manuel Salzmann; Sonja Bleichert; Bernhard Moser; Marion Mussbacher; Mildred Haase; Bastian Hoesel; Waltraud C Schrottmaier; Julia B Kral-Pointner; Makoto Itakura; Katy Schmidt; Alice Assinger; Johannes A Schmid
Journal:  Blood Adv       Date:  2020-02-25

5.  Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.

Authors:  M Endale; W M Lee; S M Kamruzzaman; S D Kim; J Y Park; M H Park; T Y Park; H J Park; J Y Cho; M H Rhee
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

6.  Proteolytic regulation of the mitochondrial cAMP-dependent protein kinase.

Authors:  Jennifer R Shell; David S Lawrence
Journal:  Biochemistry       Date:  2012-03-08       Impact factor: 3.162

7.  Reply to Schattner.

Authors:  Matthew T Rondina; Andrew S Weyrich; Guy A Zimmerman
Journal:  Circ Res       Date:  2013-10-12       Impact factor: 17.367

8.  The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood.

Authors:  C Reiss; I Mindukshev; V Bischoff; H Subramanian; L Kehrer; A Friebe; J-P Stasch; S Gambaryan; U Walter
Journal:  Br J Pharmacol       Date:  2015-10-18       Impact factor: 8.739

9.  IκB kinase phosphorylation of SNAP-23 controls platelet secretion.

Authors:  Zubair A Karim; Jinchao Zhang; Meenakshi Banerjee; Michael C Chicka; Rania Al Hawas; Tara R Hamilton; Paul A Roche; Sidney W Whiteheart
Journal:  Blood       Date:  2013-04-23       Impact factor: 22.113

Review 10.  Harnessing the platelet signaling network to produce an optimal hemostatic response.

Authors:  Lawrence F Brass; Maurizio Tomaiuolo; Timothy J Stalker
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-11       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.